These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 6296361

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo.
    Allescher HD, Daniel EE, Fox JE, Kostolanska F, Rovati LA.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1134-41. PubMed ID: 2600808
    [Abstract] [Full Text] [Related]

  • 4. Effects of amylin on feeding of goldfish: interactions with CCK.
    Thavanathan R, Volkoff H.
    Regul Pept; 2006 Jan 15; 133(1-3):90-6. PubMed ID: 16239037
    [Abstract] [Full Text] [Related]

  • 5. The effect of cholecystokinin peptides on ovine duodeno-jejunal slow waves with and without pretreatment with proglumide.
    Romański KW.
    J S Afr Vet Assoc; 2007 Dec 15; 78(4):209-14. PubMed ID: 18507220
    [Abstract] [Full Text] [Related]

  • 6. Contribution of CCK1 receptors to cardiovascular and respiratory effects of cholecystokinin in anesthetized rats.
    Kaczyńska K, Szereda-Przestaszewska M.
    Neuropeptides; 2015 Dec 15; 54():29-34. PubMed ID: 26342277
    [Abstract] [Full Text] [Related]

  • 7. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN, Stivers JA, Hommer DW, Skirboll LR, Paul SM.
    J Pharmacol Exp Ther; 1986 Feb 15; 236(2):320-30. PubMed ID: 3003339
    [Abstract] [Full Text] [Related]

  • 8. Action of cholecystokinin-octapeptide on sphincter of Oddi basal pressure and phasic wave activity in humans.
    Toouli J, Hogan WJ, Geenen JE, Dodds WJ, Arndorfer RC.
    Surgery; 1982 Sep 15; 92(3):497-503. PubMed ID: 6287657
    [Abstract] [Full Text] [Related]

  • 9. Effect of cholecystokinin-octapeptide on lower esophageal sphincter.
    Behar J, Biancani P.
    Gastroenterology; 1977 Jul 15; 73(1):57-61. PubMed ID: 863201
    [Abstract] [Full Text] [Related]

  • 10. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
    Fiedorowicz RJ, Wiśniewski K.
    Pol J Pharmacol Pharm; 1989 Jul 15; 41(6):561-72. PubMed ID: 2485904
    [Abstract] [Full Text] [Related]

  • 11. Effects of cholecystokinin octapeptide on rat cardiac function and the receptor mechanism.
    Zhao XY, Ling YL, Meng AH, Shan BE, Zhang JL.
    Sheng Li Xue Bao; 2002 Jun 25; 54(3):239-43. PubMed ID: 12075472
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Interaction of octapeptide of cholecystokinin, vasoactive intestinal peptide and substance P on dynamics of biliary system and cardiovascular system].
    Zhang J, Zou S, Qiu F.
    Zhonghua Wai Ke Za Zhi; 1997 Jan 25; 35(1):48-51. PubMed ID: 10374510
    [Abstract] [Full Text] [Related]

  • 14. Influence of octapeptide of cholecystokinin, vasoactive intestinal peptide and substance P on dynamics of biliary system and cardiovascular system.
    Zou S, Zhang J, Qiu F.
    Chin Med J (Engl); 1998 Dec 25; 111(12):1071-4. PubMed ID: 11263366
    [Abstract] [Full Text] [Related]

  • 15. Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder. Mechanisms of action.
    Behar J, Biancani P.
    J Clin Invest; 1980 Dec 25; 66(6):1231-9. PubMed ID: 7440712
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.
    Fossa AA, DePasquale MJ, Morrone J, Zorn SH, Bryce D, Lowe JA, McLean S.
    J Pharmacol Exp Ther; 1997 Apr 25; 281(1):180-7. PubMed ID: 9103496
    [Abstract] [Full Text] [Related]

  • 17. Pentobarbital causes cardiorespiratory depression by interacting with a GABAergic system at the ventral surface of the medulla.
    Yamada KA, Moerschbaecher JM, Hamosh P, Gillis RA.
    J Pharmacol Exp Ther; 1983 Aug 25; 226(2):349-55. PubMed ID: 6875848
    [Abstract] [Full Text] [Related]

  • 18. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ.
    Pol J Pharmacol; 1998 Aug 25; 50(3):203-12. PubMed ID: 9861628
    [Abstract] [Full Text] [Related]

  • 19. [Cholecystokinin-octapeptide antagonizes the central depressive effect of opioid peptides in rats].
    Mei L, Han JS.
    Sheng Li Xue Bao; 1991 Apr 25; 43(2):156-63. PubMed ID: 2068585
    [Abstract] [Full Text] [Related]

  • 20. Differential antagonism by proglumide of various CCK-mediated effects in mice.
    Barbaz BS, Autry WL, Ambrose FG, Gerber R, Liebman JM.
    Prog Clin Biol Res; 1985 Apr 25; 192():151-8. PubMed ID: 4080708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.